Phase 3
Completed N=240
AGN-229666 Ophthalmic Solution in Japanese Patients With Allergic Conjunctivitis
Conjunctivitis, Allergic
Source: ClinicalTrials.gov NCT02161146 ↗
Enrolled (actual)
240
Serious AEs
0.0%
Results posted
Mar 2016
Primary outcomePrimary: Ocular Itching Score — 0.33; 1.48; 0.29 score on a scale
Summary
This study will evaluate the safety and efficacy of AGN-229666 for the prevention of allergen-mediated conjunctivitis.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Ocular Itching Score |
0.33; 1.48; 0.29 | — |
| SECONDARY Conjunctival Hyperemia Score |
1.15; 1.61; 1.34 | — |
Eligibility Criteria
Inclusion Criteria
-Japanese patients living in Japan with a history of allergic conjunctivitis.
Exclusion Criteria
- Presence of active eye infection (bacterial, viral, or fungal)
- History of an eye herpetic infection.
Data sourced from ClinicalTrials.gov (NCT02161146). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.